SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-207818
Filing Date
2018-06-28
Accepted
2018-06-28 17:11:26
Documents
5
Period of Report
2018-08-07
Effectiveness Date
2018-06-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d589845ddef14a.htm DEF 14A 1004691
2 GRAPHIC g589845g51v37.jpg GRAPHIC 23731
3 GRAPHIC g589845g65t06.jpg GRAPHIC 27367
4 GRAPHIC g589845img1.jpg GRAPHIC 134243
5 GRAPHIC g589845img2.jpg GRAPHIC 231199
  Complete submission text file 0001193125-18-207818.txt   1580183
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37627 | Film No.: 18926242
SIC: 2834 Pharmaceutical Preparations